Wikis and Social Networks for Marketing & Sales Collaboration: Will It Work?
What do you think of the idea of a secure, internal CafePharma-type Web site where sales reps can share their triumphs and failures, vote on who has the best ideas, discuss...
FDA at a Mall Near You: The Manchurian Connection
The FDA will be coming to a mall near you...again!You previously may have seen FDA interviewers following a "mall-intercept" protocol, interrupting the shopping of about 1,800 "self-identified, moderately overweight" shoppers at...
DTC Tsunami: Duh!
A "new" study published in the NEJM concluded that "spending on direct-to-consumer advertising has continued to increase recently in absolute terms and as a percentage of pharmaceutical sales in spite...
Rozerem’s Cheapskate Sweepstakes Violates Children’s Online Privacy Protection Act
Desperate times call for desperate measures.No, I'm not talking about the "War on Terror." I am talking about about Takeda's war to win market share for its beleaguered sleep aid, Rozerem.Regular...
State Sponsored Pharma Ads: It Could Happen!
The more magazine ads smokers see for the nicotine patch and other quit-smoking aids, the more likely they are to try to quit smoking and be successful -- even without buying...
J&J Lawyers Go Wild; PR on Vacation!
J&J's recent announcement that it is filing a civil suit against the American Red Cross (ARC) has been likened by some in the blogger world to "kicking babies" (see "Trademark Law...
Takeda Plots New Rozerem Campaign?
MM&M reports that "The whimsical consumer campaign for Takeda's insomnia drug Rozerem has generated lots of buzz, just not the kind of recognition that leads to new patient starts."That the Rozerem...
Brandweek Hires Peter Rost, Moves to the Dark Side!
The pharmaceutical industry often complains that the "media" are unfriendly and biased against the industry. And at least one blog that shills for the industry -- DrugWonks run by PR agency...
The Drug Advertising Blame Game
In case you are wondering who and what to blame for everything evil about the pharmaceutical industry, consider the list of "10 reforms that drug advertising needs right now."This list was...
FDA’s Chang and Eng: Benefit vs. Risk
As reported in the Wall Street Journal, "A Food and Drug Administration advisory committee found that GlaxoSmithKline PLC's diabetes drug Avandia is tied to a risk of heart attacks, but it...
